Drug · DIN 02405539
PREGABALIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 27, 2016; first marketed June 12, 2013.
- Drug Identification Number (DIN)
- 02405539
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Pregabalin N02BF02
- Class
- Human
- Record last updated
- April 17, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PREGABALIN | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 19, 2015: NOC 17400Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
- May 1, 2013: NOC 14321Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named PREGABALIN
- DIN 02396483 · Marketed
- DIN 02396505 · Marketed
- DIN 02396513 · Marketed
- DIN 02396521 · Marketed
- DIN 02396548 · Marketed
- DIN 02403692 · Marketed
- DIN 02403706 · Marketed
- DIN 02403714 · Marketed
- DIN 02403722 · Marketed
- DIN 02403730 · Marketed
- DIN 02405547 · Marketed
- DIN 02405555 · Marketed
- DIN 02405563 · Marketed
- DIN 02405598 · Marketed
- DIN 02474352 · Marketed
- DIN 02474360 · Marketed
- DIN 02474379 · Marketed
- DIN 02474387 · Marketed
- DIN 02376946 · Cancelled Pre Market
- DIN 02376954 · Cancelled Pre Market